Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan · Delayed Price · Currency is JPY 1,549.00
+64.00 (4.31%)
Aug 31, 2026, 2:45 PM JST
Sumitomo Pharma Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 666,161 | 824,574 | 289,624 | 158,122 | 321,807 | 479,930 | |
Market Cap Growth | 10.46% | 184.70% | 83.17% | -50.86% | -32.95% | -37.31% |
Enterprise Value | 750,179 | 1,026,205 | 578,654 | 533,549 | 368,625 | 618,328 |
Last Close Price | 1485.00 | 2075.50 | 729.00 | 398.00 | 810.00 | 1180.81 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 5.36 | 7.72 | 12.26 | - | - | 8.51 |
Forward PE | 6.94 | 9.45 | 19.16 | 20.73 | 20.73 | 11.10 |
PS Ratio | 1.40 | 1.82 | 0.73 | 0.50 | 0.58 | 0.86 |
PB Ratio | 1.63 | 2.82 | 1.71 | 1.01 | 0.79 | 0.71 |
P/TBV Ratio | 18.10 | - | - | - | - | 34.15 |
P/FCF Ratio | 10.98 | 12.29 | 36.19 | - | 92.74 | 20.09 |
P/OCF Ratio | 10.33 | 11.50 | 17.55 | - | 26.96 | 15.36 |
PEG Ratio | - | 0.39 | 1.02 | 1.02 | 1.02 | 0.46 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.58 | 2.26 | 1.45 | 1.70 | 0.66 | 1.10 |
EV/EBITDA Ratio | 10.46 | 14.27 | 14.10 | - | - | 6.29 |
EV/EBIT Ratio | 14.19 | 19.43 | 32.56 | - | - | 10.31 |
EV/FCF Ratio | 12.37 | 15.29 | 72.31 | - | 106.23 | 25.88 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.39 | 0.77 | 1.85 | 2.74 | 0.85 | 0.42 |
Debt / EBITDA Ratio | 2.35 | 3.12 | 7.66 | - | - | 2.89 |
Debt / FCF Ratio | 2.65 | 3.34 | 39.27 | - | 99.82 | 11.91 |
Net Debt / Equity Ratio | 0.21 | 0.62 | 1.64 | 2.55 | 0.50 | 0.12 |
Net Debt / EBITDA Ratio | 1.23 | 2.50 | 6.77 | -1.26 | -2.38 | 0.83 |
Net Debt / FCF Ratio | 1.39 | 2.68 | 34.74 | -1.58 | 58.47 | 3.41 |
Asset Turnover | 0.60 | 0.59 | 0.48 | 0.31 | 0.46 | 0.43 |
Inventory Turnover | 2.52 | 2.15 | 1.45 | 1.21 | 1.85 | 1.64 |
Quick Ratio | 0.84 | 0.66 | 0.50 | 0.25 | 0.65 | 1.27 |
Current Ratio | 1.21 | 1.03 | 1.05 | 0.52 | 1.03 | 1.79 |
Return on Equity (ROE) | 38.53% | 46.27% | 14.52% | -111.89% | -17.90% | 6.14% |
Return on Assets (ROA) | 3.92% | 4.27% | 1.35% | -21.74% | -6.46% | 2.86% |
Return on Invested Capital (ROIC) | 10.26% | 11.48% | 3.55% | -60.99% | -18.52% | 3.91% |
Return on Capital Employed (ROCE) | 8.50% | 9.90% | 3.50% | -90.60% | -16.50% | 5.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 16.91% | 12.96% | 8.16% | -199.19% | -23.15% | 11.75% |
FCF Yield | 9.11% | 8.14% | 2.76% | -159.79% | 1.08% | 4.98% |
Dividend Yield | - | - | - | - | 2.59% | 2.37% |
Payout Ratio | 0.00% | 0.00% | 0.01% | - | - | 19.72% |
Buyback Yield / Dilution | -2.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Shareholder Return | -2.41% | - | - | - | 2.59% | 2.37% |